Azacitidine alone comparable to AZA combos for most MDS patients
HematologyTimes,
Micrograph showing MDSA 3-arm phase 2 study of azacitidine alone or in combination with lenalidomide or vorinostat in patients…
Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American…
Overview of attention for article published in Journal of Clinical Oncology, May 2017
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (97th percentile)
-
High Attention Score compared to outputs of the same age and source (94th percentile)
Mentioned by
- news
- 9 news outlets
- blogs
- 1 blog
- 23 X users
- patent
- 1 patent
- googleplus
- 1 Google+ user
- guideline
- 2 clinical guideline sources
Readers on
- mendeley
- 114 Mendeley